https://maya.tase.co.il/en/reports/details/1509447/2/0
Morgan Stanley Maintains Equal-Weight on GoodRx Holdings, Raises Price Target to $41
Morgan Stanley maintains GoodRx Holdings (NASDAQ:GDRX) with a Equal-Weight and raises the price target from $38 to $41.